Pharmalittle: We’re watching Europe moving to reject Elevidys, a FDA panel on SSRI risks, and more EU regulator reapproves GSK blood cancer drug Blenrep

https://www.statnews.com/pharmalot/2025/07/25/duchenne-elevidys-roche-sarepta-gsk-blenrep-fda-ssri-novartis-lilly-kisunla-baviarian-nordic/